Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects
maraviroc
A4001027
NCT00098306
Infection, Human Immunodeficiency Virus
Phase 2/Phase 3
 
An annotated case report form is not available for this study. A blank case report form will be provided. The clinical study report provided includes the body of the report, safety narratives and statistical tables but does not include appendices or patie
January 2014

Powered by ideaPoint, Inc.